Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
WALGREEN CO. et al v. JOHNSON & JOHNSON et al
Case Number:
2:18-cv-02357
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 26, 2019
Walgreens, Kroger Cut From J&J's Remicade Antitrust Fight
Johnson & Johnson has beaten Walgreens and Kroger's lawsuit alleging it snuffed out competition for its arthritis treatment Remicade and jacked up prices, leaving one fewer trial for the drugmaker to face amid a sprawling antitrust battle over Remicade's market dominance.
-
February 14, 2019
Walgreens, Kroger Slam J&J's Challenge To Antitrust Claims
Walgreen Co. and Kroger Co. have fired back at Johnson & Johnson's argument that the retailers don't have the right to sue the drugmaker for antitrust violations on behalf of drug wholesalers, telling a Pennsylvania court Thursday that appeals courts have repeatedly ruled that they can.
-
January 16, 2019
J&J Renews Bid To End Antitrust Suit From Walgreens, Kroger
Johnson & Johnson told a Pennsylvania federal judge Tuesday that Walgreens and Kroger can't bring antitrust claims against it for allegedly inflating prices and suppressing competition for its drug Remicade, reiterating its argument that the retailers didn't directly purchase the drug from J&J.
-
December 07, 2018
J&J Can't Escape Retailers' Antitrust Suit Over Remicade
Johnson & Johnson must face an antitrust suit accusing the drugmaker of foisting the brand drug Remicade on pharmacies and preventing them from carrying competing biosimilars, according to a Pennsylvania federal judge's ruling released Friday.
-
September 28, 2018
Walgreens, Kroger Have No Right To Sue Over Remicade: J&J
Johnson & Johnson urged a Pennsylvania federal judge Friday to toss a lawsuit from pharmacy giants Walgreens and Kroger accusing the drug company of compelling insurers not to cover biosimilar versions of the blockbuster immunosuppressant Remicade, arguing they can't participate in the closely watched antitrust fight.
-
June 06, 2018
Walgreen, Kroger Join J&J's Remicade Antitrust Brawl
Pharmacy giants Walgreen Co. and The Kroger Co. on Wednesday sued Johnson & Johnson in Pennsylvania federal court, accusing it of compelling insurers not to cover biosimilar versions of the blockbuster immunosuppressant Remicade, adding to J&J's headaches in a closely watched antitrust battle.